|
0
|
|
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75-79 years in England: a multicentre, test-negative, case-control study.
(linkinghub.elsevier.com)
|
Symes R
…
Lopez Bernal J
Lancet Infectious Diseases
2026-03-01
|
#infection
#vaccination
#immunogenicity
#rsv
|
|
0
|
|
Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial.
(linkinghub.elsevier.com)
|
Anywaine Z
…
Kaleebu P
Lancet Infectious Diseases
2026-03-01
|
#vaccination
#clinical trial
#immunogenicity
#safety
#zoonosis
|
|
0
|
|
Impact and vaccine effectiveness of the 23-valent pneumococcal polysaccharide vaccine in adults aged 65 years or older in the Netherlands.
(linkinghub.elsevier.com)
|
Niessen FA
…
van Werkhoven CH
Clinical Microbiology and Infection
2026-03-01
|
#vaccination
#epidemiology
#immunogenicity
#pneumococcal
|
|
0
|
|
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trial.
(linkinghub.elsevier.com)
|
Wagner L
…
Messier M
Lancet Infectious Diseases
2026-03-01
|
#vaccination
#clinical trial
#immunogenicity
#safety
#lyme borreliosis
|
|
0
|
|
Immunogenicity of HPV Vaccine in a High-Risk and Understudied Group: Female Sex Workers.
(academic.oup.com)
|
Van Nguyen T
…
Toh ZQ
Journal of Infectious Diseases
2026-03-01
|
#infection
#vaccination
#antibody
#immunogenicity
#hpv
|